How much melatonin should I take? Experts weigh in on dosage rules, how much is too much

OTC melatonin is not regulated by the FDA for insomnia, medical conditions or sleep disorders, so it's more easily available to the public, explained Dr. Deirdre Conroy.

That being said, studies have shown that the dose of melatonin labeled on the OTC bottle may not equal the amount you are ingesting. If you are dealing with any sleep disorder or insomnia it is best to speak with your physician to receive a prescription that has been regulated and gone through testing, according to Conroy. 

Read full article

In This Story

Deirdre A. Conroy

Deirdre A Conroy

Clinical Professor

Featured News & Stories

Purple shaded illustration of doctor listening to heart of patient on a bed
Health Lab

The AI is listening: Implications of machine generated clinical notes on health care

Michigan Medicine experts argue that use of artificial intelligent scribes during health care visits should be more carefully examined .
woman with hand covering face
Department News

What Is APS “Brain Fog”? What Are Some Strategies to Help Manage It?

The APS Program Community Q&A Series, written by Dr. Yu (Ray) Zuo, was created to answer questions we receive from the APS Program community and will cover a variety of topics. In this month’s edition, Dr. Zuo discusses brain fog.
Dr. Jacqueline Jeruss leaning against a glass rail wearing a white sweater.
Department News

Jacqueline Jeruss elected to the National Academy of Medicine

Surgical oncologist Jacqueline Jeruss, M.D., Ph.D., was elected to the National Academy of Medicine. Learn more about what this achievement means to her.
Members of the nephrology care team and Coulson family at the recent awards ceremony.
Philanthropy News

Family’s gift honors wife and mother, supports nephrology nurses

The Coulson family is honoring Barbara Coulson's memory by recognizing exceptional dialysis nurses and investing in professional development that will strengthen patient care.
headshot of Sophia Miller
Department News

Sophia Miller chosen for a position in the TRAIN Program

U-M Biological Chemistry PhD student Sophia Miller has been awarded a position in the TRAIN Program.
Gene editing, conceptual illustration. DNA (deoxyribonucleic acid) double helix under a magnifying glass
Health Lab

Gene editing is coming for common diseases. Are we ready?

Gene therapies may offer one-time treatment for disease, but experts say safety, reversibility, cost and long-term monitoring must guide use.